Search For "drugs controller general of india dcgi"
DCGI chief Dr V G Somani's term extended by 3 months
Updated : 3 years, 8 months ago IST
The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months for the second time, according to an order issued by the Union Health Ministry.
Read More
Clinical features, treatment received by children are inadequate to determ
Updated : 3 years, 9 months ago IST
New Delhi [India], October 15 (ANI): Drugs Controller General of India (DCGI) on Saturday replied to World Health Organisation (WHO) and said as per the recently formed technical committee, the clinical features and the treatment received by the children as shared by WHO so far are inadeq
Read More
DCGI allows export of approx 2 lakh doses of Malaria vaccine
Updated : 3 years, 9 months ago IST
New Delhi [India], September 29 (ANI): The Drugs controller general of India (DCGI) allowed the export of approximately 2 lakh vaccine doses of Malaria which is produced in India, said sources on Thursday.
Read More
Bharat Biotech applies for market authorisation from DCGI for five arms in
Updated : 3 years, 10 months ago IST
New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.
Read More
Bharat Biotech-made iNCOVACC becomes world's first intranasal COVID vaccin
Updated : 3 years, 10 months ago IST
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine- iNCOVACC, said officials on Tuesday.
Read More
COVID-19: India's first intranasal vaccine by Bharat Biotech gets DCGI app
Updated : 3 years, 10 months ago IST
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
Read More
DCGI chief Venugopal Somani's tenure extended by 3 months
Updated : 3 years, 11 months ago IST
New Delhi [India], August 17 (ANI): The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months, according to an order issued by the Union Health Ministry.
Read More
DCGI approves India's first qHPV vaccine to treat cervical cancer
Updated : 4 years ago IST
New Delhi [India], July 12 (ANI): India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India (DCGI) approval for market authorisation. This vaccine will be manufactured by the Serum Institute of India (SII).
Read More
SII's Covovax gets DCGI emergency use nod for children between 7-12 years
Updated : 4 years ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation (EUA) to Pune-based Serum Institute of India's COVID-19 vaccine 'Covovax' for children aged 7 to 12 years, sources told ANI.
Read More
DCGI gives emergency use authorisation to India's first mRNA COVID-19 vacc
Updated : 4 years ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has approved two doses of Pune-based Gennova Biopharmaceuticals' mRNA COVID-19 vaccine for restricted use in emergency situations for beneficiaries aged above 18 years age group.
Read More
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated : 4 years ago IST
Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Read More
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials i
Updated : 4 years, 2 months ago IST
New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.
Read More